about
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer PatientsPregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinomathe Clinicaltrail of the Effection Which of Phrenic Block Using in Non-intubated Video-assisted Thoracoscopic SurgeryTislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaBiomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary SyndromeSensor-equipped Ultrathin Pressure Microcatheter Versus Pressure Wire for FFR MeasurementChina Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and HypertensionPeriOperative ISchemic Evaluation-3 TrialClinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in ChinaPhase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)Comparisons of SWI, WWI and CI in Potentially Difficult Colonoscopy.Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLCClinical Applications of a Joystick in Femoral Shaft FracturesNimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral GlioblastomaIcotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
P6153
To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinomathe Clinicaltrail of the Effection Which of Phrenic Block Using in Non-intubated Video-assisted Thoracoscopic SurgeryBiomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)Association of Beta-Blocker Therapy at Discharge With Clinical Outcomes in Patients With Actue Coronary SyndromeComparisons of SWI, WWI and CI in Potentially Difficult Colonoscopy.Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLCRALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
P859
Q59984708-F9F8F319-A3E0-4FE6-BE8B-2A0DB5738FAFQ60397369-7ECDEB0F-B74B-462E-A7FB-2A1B3D2C82C4Q60965434-4A6A925A-652F-45CC-9E2B-030B188317F8Q61799034-2FB6C1CD-7D71-4295-90C9-B55A7613FEB5Q83481338-F1079406-3456-4476-B501-5E10E4C519BAQ84367153-19CCB044-AFBD-4821-AD58-33ED75EF6A15Q86805773-20C83310-92D1-45A7-86A4-7A846939B7A4Q87173978-97729081-1527-4FB6-999B-AF4E570FEF5DQ87173980-F25BB357-1242-4448-9C63-E968D4B52D5AQ87190473-9C6AC202-B680-49AF-8CBF-28436CB435C2Q87349235-752CCD4B-762F-4D03-B4F5-34CE24E92616Q87353863-2956B6D2-2F25-4094-A24A-D676D6F7DB7CQ88187476-0E8EE6B3-140F-4D90-B336-D919C9AFAA2DQ89422235-188ED947-2BA7-4353-A8FA-EA34FDAB7DFDQ89461507-4767D769-F1F1-48F0-A4AB-582923FAC938Q89702427-53BAC2B0-9030-4E49-BB99-45ECCB9477B7Q89702431-AAE44910-52BA-4F55-A0C1-7FFC7DAA614BQ89702434-20BDB0A8-B0B9-4973-9017-D3FDC8FA6601Q89702437-2A34FD4E-CCCC-44E7-888A-F457D2E78343Q89794470-74B2705B-46B8-4E93-A37F-A7A25CFA274C
P108
Q61957364-E0E6740B-81BA-4F13-BEBB-BCC48F86A864Q61966144-B011FCFC-BE62-4219-9A9F-9CD9D41EB9FEQ62024897-C4EBC8B6-0A9B-4358-8BE5-6700431E3F0EQ62025157-E15A45AF-77CD-48D6-82A1-640C78FC8059Q62030726-B7A538DE-28F0-4093-B515-985902DC62E7Q62034672-C547BA47-F9CE-481F-8518-F34FB3746B59Q62062525-80271986-2AB8-42D1-AAA1-1D71FF951B04Q62811739-1D6DC716-2254-4D80-9E13-11372D2165ABQ62815627-E1B9337F-DDBE-4D04-B434-1A86FD790E40Q62823313-6A044368-BE51-4007-BAE9-F2683C7585B3Q63229583-D8F6169E-9177-423C-957D-62506F649422Q63320096-A8C70C52-9B28-4C15-B8BE-8396475D6E3FQ63397384-838F9D17-A266-4996-8394-99CD03A8C7F6Q63401112-7EDE427B-FBF2-4FBB-AA99-DBC6013D760DQ63404481-CE2F3118-3FE0-4764-A7AF-E310713CD519Q63405592-A7AEEF9D-3D1D-45C0-BE3D-E89610ABFEF9Q64172354-AE0400C7-1960-4D82-9031-624C8CAD3BC4
P6153
Q62024897-A0D1A8B7-E265-4AC7-9497-1B475C1C74F1Q62025157-9D117B29-F00F-4B31-88C7-15310CC12C0AQ62034672-6CE3D919-7A80-4C35-8438-B095CC971840Q62062525-EA1DEC9E-61E3-4474-9DBB-C0A4B99BF8D3Q63397384-478A97CF-E960-4F0A-BEBD-63DABE4A54DEQ63401112-B4106150-09EF-4A8C-8A0D-7A35995CA1FAQ63582754-2CF1028A-A24A-4448-9D46-6429817FAB2EQ63599763-E51C0868-A16B-4D50-808E-BFA35C97F9DD
P859
description
griya sakit
@jv
healthcare organization in Shenzhen, China
@en
rumah sakik
@min
rumah sakit di Republik Rakyat Tiongkok
@id
rumoh sakét
@ace
مستشفى في شينزين، الصين
@ar
name
ShenZhen People’s Hospital
@en
深圳市人民医院
@zh
type
label
ShenZhen People’s Hospital
@en
深圳市人民医院
@zh
altLabel
2nd Clinical Medical College of Jinan University
@en
Bao'an County People's Hospital
@en
prefLabel
ShenZhen People’s Hospital
@en
深圳市人民医院
@zh
P131
P213
0000 0004 1759 7210
P2427
grid.440218.b
P3500
P625
Point (114.128502 22.5561)